Evidence map›Paper›PMID 31352580›Full record

ReviewInternational urology and nephrology2019

Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.

Mahmoud I Khalil, Jeffrey T Alliston, Jonathan J Bauer-Erickson, Rodney Davis, Nabil K Bissada, Mohamed H Kamel

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urology and nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mahmoud I KhalilDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Jeffrey T AllistonDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Jonathan J Bauer-EricksonDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Rodney DavisDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Nabil K BissadaDepartment of Urology, Baylor College of Medicine and Michael E. De Bakey VA Medical Center, Houston, TX, USA.
Mohamed H KamelDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. mkamel@uams.edu.ORCID http://orcid.org/0000-0002-7118-1000
University of Arkansas for Medical Sciences · USAin Shams University · EGMichael E. DeBakey VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe impact of radical surgery for urothelial carcinoma is significant on patient's quality of life. Organ-sparing surgery (OSS) can provide comparable oncological outcomes and with improved quality of life. In this review, we summarize the indications, techniques and outcomes of OSS for these tumors.

methodsPubMed

resultsKidney-sparing surgery is an option in patients with low-risk UTUC with better renal function preservation and comparable oncological control to radical nephroureterectomy. In select patients with MIBC, trimodal therapy has better quality of life and comparable oncological control to radical cystectomy. In distal male urethral cancer, penile conserving surgery is feasible and offers acceptable survival outcomes. In female urethral cancer, organ preservation can be achieved, in addition to OSS, through radiation.

conclusionsIn the appropriately selected patient, OSS in upper tract, bladder and urethral carcinoma has comparable oncological outcomes to radical surgery and with the additional benefit of improved quality of life.

Indexed as

Carcinoma, Transitional CellHumansOrgan Sparing TreatmentsPractice Guidelines as TopicUreteral NeoplasmsUrinary Bladder NeoplasmsBladder preservationMuscle invasive bladder cancerPenile sparingPercutaneous managementTrimodal therapyUpper tract urothelial cancerUreteroscopic managementUrethral carcinomaUrethra sparing

Identifiers

PMID31352580
OpenAlexW2964849630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.